Jan 7, 2009 | 4
Hey, ladies, been spending hours fretting over your beefy bottoms? Perturbed about your pear-shaped bodes no matter how many lunges you do daily? Don't be. Turns out that having a little extra cushioning around your derriere and hips—think Jennifer Lopez—may be a sign of good health.
Harvard Medical School researchers report in the journal Cell Metabolism that fat around the hips and buttocks may protect women from type 2 diabetes and other diseases by releasing certain beneficial hormones. They say that mice injected in their bellies with flab from those areas made better use of the hormone insulin in breaking down sugar in the blood (a key to preventing diabetes)—and they lost weight.
"The surprising thing was that it wasn't where the fat was located, it was the kind of fat that was the most important variable," researcher Ronald Kahn of Harvard's Joslin Diabetes Center in Boston told FOX News. "Even more surprising, it wasn't that the abdominal fat was exerting negative effects, but that subcutaneous fat was producing a good effect. I think that's an important result because not only does it say that not all fat is bad, but I think it points to a special aspect of fat where we need to do more research."
Sep 8, 2008 | 3
More evidence today that our genes aren't always our destiny — with an inconvenient caveat for couch potatoes: Physically active people who carry gene mutations linked to obesity are no more likely to be overweight than those without the variants — as long as they exercise at least three hours a day.
Scientists monitored the physical activity of 704 Amish men and women for a week with accelerometers, devices worn on the hip that keep tabs on movement. Those who carried two copies of the FTO gene variant, which previously has been shown to increase the risk of obesity, had a 27 percent risk of being fat, compared to a 16 percent risk among those who had no mutations on the gene. But heavy labor such as brisk walking, house-cleaning and gardening canceled out the gene's weight-gaining effect.
Sep 8, 2008 | 3
A new once-a-week diabetes treatment may soon provide relief for millions of people with Type 2 diabetes (the variety of the disease associated with obesity that can be prevented with proper diet and exercise). Researchers report online in The Lancet today that a long-acting version of the diabetes drug exenatide controlled blood sugar levels during clinical trials better than the current two-times-a-day dosage of the same medication.
Patients with Type 2 diabetes either do not produce enough insulin or have cells that do not respond to insulin normally. Exenatide (also known as Byetta) mimics incretins, hormones that are naturally secreted by the intestines and that, in turn, increase insulin levels after eating. The drug increases the body's natural insulin secretion in response to food and slows food's journey through the stomach.
Deadline: Jan 11 2014
Reward: $20,000 USD
Conventional washing machines cause excessive damage and wrinkling to clothes primarily during the water removal step. With the introduc
Deadline: Jan 27 2014
Reward: $15,000 USD
The Dow Chemical Company is the leading producer of polyalkylene glycols (PAGs) used in synthetic fluids and lubricants where petroleum,
Give a 1 year subscription as low as $14.99X